OptimizeRx AI pilot identifies non-adherence risks

Patients can experience unexpected access and affordability barriers that physicians lack visibility into, but by searching for the early indicators of non-adherence, physicians could act to help patients stay on their treatment plans.
Rochester, Michigan-based OptimizeRx Corp., which provides…
Source: Healthcareitnews.com and Read More